| 10007266 |
(±)11,12-DHET Lipid Maps MS Standard
|
|
- |
≥98%
|
|
|
2009-02-11
|
52.514077348066
|
-11-12-dhet-lipid-maps-ms-standard
|
(±)11,12-DiHETrE
|
epoxides epoxygenases DHTs hydrolases (+/-)11,12-DiHETrEs MS mass spectrometry standards |
52.514077348066
|
| 37505 |
11(R)-HEDE
|
|
- |
≥98%
|
|
|
|
0.216500920810
|
11-r-hede
|
|
hydroxy fatty acids cyclooxygenases COX PGHS prostaglandin synthases 11R-HEDEs 11-HEDEs 11(R)HEDEs eicosadienoic 11(R)-HEDEs |
0.216500920810
|
| 34590 |
12(S)-HHTrE
|
|
54397-84-1 |
≥97%
|
|
|
|
52.589631675875
|
12-s-hhtre
|
12(S)-HHT
|
platelets thromboxanes hydroxy acids 12S-HHTrEs 12-HHTrEs fatty atherosclerosis 12(s)-hhtre 12(s)-hhtre |
52.589631675875
|
| 10007250 |
12(S)-HHTrE Lipid Maps MS Standard
|
|
54397-84-1 |
≥97%
|
|
|
2009-02-26
|
35.295558011050
|
12-s-hhtre-lipid-maps-ms-standard
|
12-HHT
|
platelets thromboxanes hydroxy acids 12S-HHTrEs 12-HHTrEs fatty atherosclerosis MS mass spectrometry standards |
35.295558011050
|
| 10141 |
15-deoxy-Δ12,14-Prostaglandin J2-biotin
|
|
- |
>98%
|
|
|
2005-10-11
|
34.721527229676
|
15-deoxy-12-14-prostaglandin-j2-biotin
|
15-deoxy-Δ12,14-PGJ2-biotin
|
affinity probes binding proteins cyclopentenones PGs prostaglandins peroxisomes proliferator-activated receptors PPARs anitmitotic antiproliferative genes expressions non-classical non-GPCR gene protein-coupled detected detection interactions biotins ligands complexes nuclear nucleic acids elucidations mechanisms biotinylated PGJ2 biotinamides |
34.721527229676
|
| 10009799 |
17(S)-HDoHE
|
|
- |
≥98%
|
|
|
2007-03-12
|
10.232854511970
|
17-s-hdohe
|
17(S)-hydroxy Docosahexaenoic Acid
|
resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 17(s)-hdohe |
10.232854511970
|
| 90030 |
20-HETE
|
|
79551-86-3 |
≥98%
|
|
|
|
66.338568558513
|
20-hete
|
20-hydroxy Arachidonic Acid
|
hydroxy fatty acids omega-oxidation .omega.-oxidation w-oxidation cytochrome P450 CYP450 arachidonic HETEs metabolites P-450 vasoconstrictors vasoconstriction |
66.338568558513
|
| 390030 |
20-HETE-d6
|
|
- |
≥99% deuterated product
|
|
|
|
77.450497237569
|
20-hete-d6
|
20-hydroxy Arachidonic Acid-d6
|
CYP450 vasocontriction standards vasoconstrictors GC-MS GC/MS LC-MS LC/MS cytochrome chromatography mass spectroscopy deuterium deuterateds |
77.450497237569
|
| 10007269 |
20-HETE Lipid Maps MS Standard
|
|
79551-86-3 |
≥98%
|
|
|
2009-02-18
|
22.125657458563
|
20-hete-lipid-maps-ms-standard
|
20-hydroxy Arachidonic Acid
|
hydroxy fatty acids omega-oxidation .omega.-oxidation w-oxidation cytochrome P450 CYP450 arachidonic HETEs metabolites P-450 vasoconstrictors vasoconstriction MS mass spectrometry standards |
22.125657458563
|
| 51211 |
(±)5,6-DHET
|
|
213382-49-1 |
≥98%
|
|
|
|
12.326657458563
|
-5-6-dhet
|
(±)5,6-DiHETrE
|
epoxides epoxygenases DHT hydrolases (+/-)5,6-DiHETrEs |
12.326657458563
|
| 10007264 |
(±)5,6-DHET Lipid Maps MS Standard
|
|
- |
≥98%
|
|
|
2009-02-14
|
7.868591160221
|
-5-6-dhet-lipid-maps-ms-standard
|
(±)5,6-DiHETrE
|
epoxides epoxygenases DHT hydrolases (+/-)5,6-DiHETrEs MS mass spectrometry standards |
7.868591160221
|
| 90200 |
5,8,11-Eicosatriynoic Acid
|
|
13488-22-7 |
≥99%
|
|
|
|
14.012469613259
|
5-8-11-eicosatriynoic-acid
|
5,8,11-ETI
|
acetylene inhibitors lipoxygenase cyclooxygenase fatty acids |
14.012469613259
|
| 70265 |
5-Aminosalicylic Acid
|
|
89-57-6 |
>99%
|
|
|
|
2.050757695343
|
5-aminosalicylic-acid
|
5-ASA
|
aspirin 5asa acids COX-1 COX-2 cox1 cox2 cyclooxygenases prostaglandin synthases synthase-1 synthase-2 pghs1 pghs2 pghs-1 pghs-2 ltb4 leukotriene |
2.050757695343
|
| 70620 |
6-methoxy Naphthalene Acetic Acid
|
|
23981-47-7 |
>99%
|
|
|
|
21.536888888888
|
6-methoxy-naphthalene-acetic-acid
|
6-MNA
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits |
21.536888888888
|
| 10007900 |
8,11,14-Eicosatriynoic Acid
Exclusive |
|
34262-64-1 |
≥98%
|
|
✓ |
2007-03-12
|
0E-12
|
8-11-14-eicosatriynoic-acid
|
8,11,14-ETI
|
Cyclooxygenases COX 12-LO 15-LO 5-LO Inhibitor Fatty acids Acetylenic Lipoxygenases SRS-A FA |
0E-12
|
| 90100 |
8,11-Eicosadiynoic Acid
|
|
82073-91-4 |
≥95%
|
|
|
|
2.692099447514
|
8-11-eicosadiynoic-acid
|
EDYA
|
acetylene inhibitors delta-5-desaturase cyclooxygenases .DELTA.-5-desaturase D-5-desaturase inhibits fatty acids D5-desaturase |
2.692099447514
|
| 51351 |
(±)8,9-DHET
|
|
192461-96-4 |
≥98%
|
|
|
|
11.931160220995
|
-8-9-dhet
|
(±)8,9-DiHETrE
|
epoxides epoxygenases DHT hydrolases (+/-)8,9-DiHETrEs |
11.931160220995
|
| 10007265 |
(±)8,9-DHET Lipid Maps MS Standard
|
|
- |
≥98%
|
|
|
2009-02-11
|
7.775953038674
|
-8-9-dhet-lipid-maps-ms-standard
|
(±)8,9-DiHETrE
|
epoxides epoxygenases DHT hydrolases (+/-)8,9-DiHETrEs MS mass spectrometry standards |
7.775953038674
|
| 70260 |
Aspirin
|
|
50-78-2 |
>99%
|
|
|
|
10.936541659691
|
aspirin
|
Acetylsalicylic Acid
|
atherosclerosis cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits |
10.936541659691
|
| 70210 |
CAY10404
|
|
- |
>98%
|
|
|
|
37.777254869133
|
cay10404
|
|
COX-2 inhibitors PGHS-2 COX2 PGHS2 prostaglandins synthases NSAIDS selective selectivity inhibits inhibition cyclooxygenase |
37.777254869133
|
| 70635 |
CAY10416
|
|
443919-96-8 |
>95%
|
|
|
2007-07-24
|
28.782914364640
|
cay10416
|
|
COX-2 cyclooxygenases 5-LO lipoxygenases inflammation inhibitors prostates cancers PC3 LNCaP carcinomas apoptosis inhibition inhibits chemotherapy cells lines |
28.782914364640
|
| 160110 |
COX-1 Monoclonal Antibody (Clone CX111)
|
|
- |
|
|
|
|
44.420428176795
|
cox-1-monoclonal-antibody-clone-cx111
|
PGHS-1; Prostaglandin H Synthase 1; Cyclooxygenase 1
|
prostaglandins inflammation cancer arthritis antibodies cox1 pghs1 pghs-1 synthases cyclooxygenases western blots blotting WB antisera antiserum immunohistochemistry IHC immunocytochemistry ICC antisera antiserum atherosclerosis immunoblotting |
44.420428176795
|
| 160111 |
COX-1 Monoclonal FITC Antibody (Clone CX111)
|
|
- |
|
|
|
|
31.501961325966
|
cox-1-monoclonal-fitc-antibody-clone-cx111
|
PGHS-1; Prostaglandin H Synthase 1; Cyclooxygenase 1
|
prostaglandins inflammation cancer arthritis flow cytometry antibodies antisera antiserum cyclooxygenase FC icc immunocytochemistry IF immunofluorescence |
31.501961325966
|
| 160120 |
COX-1 Monoclonal PE Antibody (Clone CX111)
|
|
- |
|
|
|
|
39.864022099447
|
cox-1-monoclonal-pe-antibody-clone-cx111
|
PGHS-1; Prostaglandin H Synthase 1; Cyclooxygenase 1
|
prostaglandins inflammation cancers arthritis Flow cytometry phycoerythrin ovine antibodies P.E. cox1 pghs-1 pghs1 synthases sheep antisera antiserum cyclooxygenases FC ICC immunocytochemistry IF immunofluorescence |
39.864022099447
|
| 160109 |
COX-1 (mouse) Polyclonal Antibody
|
|
- |
|
|
|
|
38.133563535911
|
cox-1-mouse-polyclonal-antibody
|
PGHS-1; Prostaglandin H Synthase 1; Cyclooxygenase 1
|
prostaglandins inflammation cancer arthritis antibodies mouse cox1 pghs1 pghs-1 cyclooxygenase-1 cyclooxygenases synthase-1 synthases antiserum antisera western blots blotting wb IHC immunohistochemistry atherosclerosis immunoblotting |
38.133563535911
|
| 360109 |
COX-1 (murine) Blocking Peptide
|
|
- |
|
|
|
|
29.672044198895
|
cox-1-murine-blocking-peptide
|
Prostaglandin H Synthase 1 (murine); Cyclooxygenase 1 (murine); PGHS-1
|
IHC immunohistochemistry Western blots blotting PGHS-1 PGHS1 COX1 cyclooxygenases prostaglandins synthases controls peptides mouse antibodies |
29.672044198895
|
| 60100 |
COX-1 (ovine)
|
|
- |
>95%
|
|
|
|
132.372501255650
|
cox-1-ovine
|
Prostaglandin H Synthase 1; Prostaglandin Endoperoxide Synthase; Cyclooxygenase 1
|
cyclooxygenases COX-1 enzymes PGHS1 PGHS-1 constitutive prostaglandins synthases 1 sheep 760110 tween 20 |
132.372501255650
|
| 360108 |
COX-1 (ovine) Blocking Peptide
|
|
- |
|
|
|
|
30.465091372715
|
cox-1-ovine-blocking-peptide
|
Prostaglandin H Synthase 1; Cyclooxygenase 1; PGHS-1
|
PGHS-1 COX1 western blots blotting immunohistochemistry cyclooxygenases sheep pghs1 synthases controls peptides prostaglandins IHC antibodies |
30.465091372715
|
| 360100 |
COX-1 (ovine) Electrophoresis Standard
|
|
- |
>95%
|
|
|
|
9.809944751381
|
cox-1-ovine-electrophoresis-standard
|
Prostaglandin H Synthase 1; Cyclooxygenase 1; PGHS-1
|
PGHS-1 sheep COX1 Western blots immunoblotting cyclooxygenases pghs1 synthases standards prostaglandins antibodies |
9.809944751381
|
| 160108 |
COX-1 (ovine) Polyclonal Antiserum
|
|
- |
|
|
|
|
9.430530386740
|
cox-1-ovine-polyclonal-antiserum
|
PGHS-1; Prostaglandin H Synthase 1; Cyclooxygenase 1
|
prostaglandins inflammation cancer arthritis Western blots blotting sheep antisera wb antibody antibodies ihc icc immunohistochemistry immunocytochemistry antiserum cyclooxygenase immunoblotting |
9.430530386740
|
| 360107 |
COX-2 (human) Blocking Peptide
|
|
- |
|
|
|
|
34.308563535911
|
cox-2-human-blocking-peptide
|
Prostaglandin H Synthase 2; Cyclooxygenase 2; PGHS-2
|
peptides prostaglandins PGHS-2 COX2 PGHS2 western blots blotting synthases controls immunohistochemistry IHC cyclooxygenases WB antibodies |
34.308563535911
|
| 160107 |
COX-2 (human) Polyclonal Antibody
|
|
- |
|
|
|
|
37.640005022601
|
cox-2-human-polyclonal-antibody
|
PGHS-2; Prostaglandin H Synthase 2; Cyclooxygenase 2
|
prostaglandins inflammation cancer arthritis antibodies antisera antiserum wb ihc icc western blots blotting immunohistochemisty immunocytochemisty cyclooxygenase immunoblotting |
37.640005022601
|
| 60122 |
COX-2 (human recombinant)
|
|
- |
>70%
|
|
|
|
134.936866175567
|
cox-2-human-recombinant
|
Prostaglandin H Synthase 2; Cyclooxygenase 2
|
cyclooxygenases COX2 PGHS-2 PGHS2 inducible synthases synthase-2 prostaglandins enzymes |
134.936866175567
|
| 10009624 |
COX-2 (human) Western Ready Control
|
|
- |
Whole cell lysate
|
|
|
2007-04-30
|
52.972715074979
|
cox-2-human-western-ready-control
|
Cyclooxygenase-2; Prostaglandin H Synthase 2
|
western blots WB PGHS-2 Prostaglandin H Synthase 2 cyclooxygenase 2 |
52.972715074979
|
| 160112 |
COX-2 Monoclonal Antibody (Clone CX229)
|
|
- |
|
|
|
|
92.953200736648
|
cox-2-monoclonal-antibody-clone-cx229
|
PGHS-2; Prostaglandin H Synthase 2; Cyclooxygenase 2
|
prostaglandins inflammation cancers arthritis western blots blotting immunohistochemistry IHC WB immunocytochemistry ICC antibodies cox2 pghs2 pghs-2 synthases cyclooxygenases antisera antiserum cyclooxygenase immunoblotting |
92.953200736648
|
| 160113 |
COX-2 Monoclonal FITC Antibody (Clone CX229)
|
|
- |
|
|
|
|
30.159055750879
|
cox-2-monoclonal-fitc-antibody-clone-cx229
|
PGHS-2; Prostaglandin H Synthase 2; Cyclooxygenase 2
|
prostaglandins inflammation cancers arthritis flow cytometry antibodies cox2 pghs2 pghs-2 synthases cyclooxygenases antisera antiserum FC |
30.159055750879
|
| 160106 |
COX-2 (mouse) Polyclonal Antibody
|
|
- |
|
|
|
|
91.487865035516
|
cox-2-mouse-polyclonal-antibody
|
PGHS-2; Prostaglandin H Synthase 2; Cyclooxygenase 2
|
prostaglandins inflammation cancer arthritis cox2 synthases pghs2 pghs-2 antibodies antisera antiserum wb ihc western blots blotting immunohistochemistry icc immunocytochemistry cyclooxygenase immunoblotting |
91.487865035516
|
| 160126 |
COX-2 (mouse) Polyclonal Antibody
|
|
- |
|
|
|
|
119.955016574585
|
cox-2-mouse-polyclonal-antibody
|
PGHS-2; Prostaglandin H Synthase 2; Cyclooxygenase 2
|
immunohistochemistry IHC Western blotting WB antibodies blots cox2 PGHS2 PGHS-2 synthases prostaglandins mouse cyclooxygenases antisera antiserum cancers immunoblotting |
119.955016574585
|
| 160116 |
COX-2 (mouse) Polyclonal Antiserum
|
|
- |
|
|
|
|
29.046483820047
|
cox-2-mouse-polyclonal-antiserum
|
PGHS-2; Prostaglandin H Synthase 2; Cyclooxygenase 2
|
prostaglandins inflammation cancer arthritis Western blots blotting WB antisera cox2 pghs2 pghs-2 synthases cyclooxygenases antibodies antiserum IHC immunohistochemistry immunoblotting |
29.046483820047
|
| 360106 |
COX-2 (murine) Blocking Peptide
|
|
- |
|
|
|
|
45.178356353591
|
cox-2-murine-blocking-peptide
|
Prostaglandin H Synthase 2; Cyclooxygenase 2; PGHS-2
|
PGHS-2 mouse COX2 pghs2 synthases western blots blotting immunohistochemistry IHC cyclooxygenases peptides controls prostaglandins WB antibodies |
45.178356353591
|
| 60120 |
COX-2 (ovine)
|
|
- |
~70%
|
|
|
|
110.270283609576
|
cox-2-ovine
|
Prostaglandin H Synthase 2; Inducible cyclooxygenase (ovine); Cyclooxygenase 2
|
cyclooxygenases COX2 PGHS-2 PGHS2 inducible sheep synthases synthase-2 enzymes 760112 |
110.270283609576
|
| 360120 |
COX-2 (ovine) Electrophoresis Standard
|
|
- |
>95%
|
|
|
|
40.503370165746
|
cox-2-ovine-electrophoresis-standard
|
Prostaglandin H Synthase 2; Cyclooxygenase 2; PGHS-2
|
standards prostaglandins PGHS-2 sheep COX2 pghs2 synthases western blots immunoblotting cyclooxygenases antibodies |
40.503370165746
|
| 760151 |
COX Activity Assay Kit
|
|
- |
|
|
|
|
100.310974384731
|
cox-activity-assay-kit
|
|
cyclooxygenases synthases cox-1 cox1 cox-2 cox2 prostaglandin synthase-1 synthase-2 pghs-1 pghs1 pghs-2 pghs2 assays kits peroxidase activity analysistools:cox |
100.310974384731
|
| 700200 |
COX Fluorescent Activity Assay Kit
|
|
- |
|
|
|
2008-07-24
|
77.425905102372
|
cox-fluorescent-activity-assay-kit
|
Cyclooxygenase Fluorescent Activity Assay Kit
|
cyclooxygenases synthases enzymes cox-1 cox1 cox-2 cox2 prostaglandins PGs synthase-1 synthase-2 pghs-1 pghs1 pghs-2 pghs2 assays kits peroxidase activity cellular homeostasis antiinflammatory NSAIDs nonsteroidal anti-inflammatory drugs fluorescence human recombinant ovine isozyme-specific inhibits inhibitors inhibition ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin |
77.425905102372
|
| 700100 |
COX Fluorescent Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2008-07-08
|
104.108034727703
|
cox-fluorescent-inhibitor-screening-assay-kit
|
Cyclooxygenase Fluorescent Inhibitor Screening Assay Kit
|
cyclooxygenases synthases enzymes cox-1 cox1 cox-2 cox2 prostaglandins PGs synthase-1 synthase-2 pghs-1 pghs1 pghs-2 pghs2 assays kits peroxidase activity cellular homeostasis antiinflammatory NSAIDs nonsteroidal anti-inflammatory drugs fluorescence human recombinant ovine isozyme-specific inhibits inhibitors inhibition ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin |
104.108034727703
|
| 10186 |
COX Inhibitor Pack
|
|
- |
≥98%
|
|
|
|
31.989613259668
|
cox-inhibitor-pack
|
Cyclooxygenase-PAK
|
cyclooxygenases PGHS-2 inducible synthases prostaglandins CAY10404 SC-560 SC-58125 valeroyl saliylate NS-398 aspirin resveratrol APHS inhibitors inhibits inhibition SC560 SC58125 NS 398 COX-2 COX2 COX-1 COX1 PGHS2 PGHS-1 PGHS1 10186 70330 70655 10006120 10007692 valdecoxib licofelone packs |
31.989613259668
|
| 560131 |
COX Inhibitor Screening Assay Kit
|
|
- |
|
|
|
|
266.667369685322
|
cox-inhibitor-screening-assay-kit
|
|
enzyme immunoassays kits measures EIAs ELISAs COX1 COX-1 COX2 COX-2 PGHS1 pghs-1 pghs2 pghs-2 prostaglandin synthases inhibitors cyclooxygenase analysistools:eia assays cox inhibitior kit |
266.667369685322
|
| 560101 |
COX (ovine) Inhibitor Screening Assay Kit
|
|
- |
|
|
|
|
116.705390686660
|
cox-ovine-inhibitor-screening-assay-kit
|
|
enzyme immunoassays kits measures EIAs ELISAs COX1 COX-1 COX2 COX-2 PGHS1 pghs-1 pghs2 pghs-2 prostaglandin synthases inhibitors cyclooxygenases sheep screens assays cox inhibitior kit |
116.705390686660
|
| 160103 |
COX Polyclonal Antibody
|
|
- |
|
|
|
|
33.239193370165
|
cox-polyclonal-antibody
|
PGHS; Prostaglandin H Synthase; Cyclooxygenase
|
prostaglandins inflammation cancer arthritis antibodies antisera antiserum wb ihc western blots blotting immunohistochemistry cyclooxygenase immunoblotting |
33.239193370165
|
| 70680 |
Diclofenac (sodium salt)
|
|
15307-79-6 |
≥99%
|
|
|
|
33.720924902803
|
diclofenac-sodium-salt
|
Voltaren; Ecofenac; Benfofen
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits |
33.720924902803
|
| 70645 |
DuP-697
|
|
88149-94-4 |
≥96%
|
|
|
|
14.240696132596
|
dup-697
|
|
COX-2 COX2 PGHS2 prostaglandins H synthases inhibitors inhibits selective time-dependent cyclooxygenase DuP697 DuP 697 |
14.240696132596
|
| 70530 |
Ebselen
|
|
60940-34-3 |
≥99%
|
|
|
|
221.665497237568
|
ebselen
|
|
glutathione peroxidase peroxynitrite oxidative injury stress cyclooxygenases lipoxygenases LOX 5-LO 12-LO 15-LO cyclooxygenases inhibitors COX-1 COX-2 cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits mimics scavengers |
221.665497237568
|
| 90120 |
Eicosatetraynoic Acid
|
|
1191-85-1 |
>98%
|
|
|
|
5.221602209945
|
eicosatetraynoic-acid
|
ETYA
|
inhibitors inhibits lipoxygenases cyclooxygenases prostaglandin h synthases cox lo acetylene PPAR ligands peroxisome proliferator-activated receptors fatty acids |
5.221602209945
|
| 70250 |
(±)-Flurbiprofen
|
|
5104-49-4 |
≥99%
|
|
|
|
83.073017188458
|
-flurbiprofen
|
Ansaid
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases neurochemistry synthase-1 synthase-2 inhibits 51543-38-5 |
83.073017188458
|
| 10039 |
FR122047 (hydrate)
|
|
- |
≥98%
|
|
|
|
9.722624309392
|
fr122047-hydrate
|
|
130717-51-0 FR-122047 cyclooxygenases COX-1 inhibitors hydrates hydrochlorides COX1 PGHS1 PGHS-1 prostaglandin synthases inhibition inhibits selective selectivity platelet aggregation antiinflammatory atherosclerosis |
9.722624309392
|
| 100034 |
Goat Anti-COX-2 (human) Affinity-Purified Polyclonal Antibody
|
|
- |
|
|
|
2004-04-21
|
67.700448895027
|
goat-anti-cox-2-human-affinity-purified-polyclonal-antibody
|
PGHS-2; Prostaglandin H Synthase-2; Cyclooxygenase-2
|
prostaglandins inflammation antibodies antisera antiserum wb ihc icc western blots blotting immunohistochemisty immunocytochemisty cyclooxygenases anticox2 anticox-2 immunoblotting |
67.700448895027
|
| 70280 |
(±)-Ibuprofen
|
|
15687-27-1 |
≥99%
|
|
|
|
26.545411574306
|
-ibuprofen
|
Motrin
|
PPAR cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits peroxisome proliferator-activated receptors neurochemistry |
26.545411574306
|
| 70270 |
Indomethacin
|
|
53-86-1 |
≥99%
|
|
|
|
30.082153361624
|
indomethacin
|
Indocin
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin synthases synthase-1 synthase-2 PPARs peroxisome proliferator-activated receptors inhibits neurochemistry |
30.082153361624
|
| 70271 |
Indomethacin heptyl ester
|
|
- |
≥98%
|
|
|
|
3.228397790055
|
indomethacin-heptyl-ester
|
|
esters derivatives COX-2 cox2 pghs2 pghs-2 prostaglandin synthases synthase-2 inhibitors inhibits selective selectivity cyclooxygenase |
3.228397790055
|
| 70273 |
Indomethacin N-octyl amide
|
|
- |
≥98%
|
|
|
|
21.691063535911
|
indomethacin-n-octyl-amide
|
|
aromatic amides inhibitors inhibits COX-2 COX2 PGHS2 PGHS-2 prostaglandin synthases cyclooxygenases selective selectivity |
21.691063535911
|
| 10006661 |
Ketoprofen
|
|
22071-15-4 |
≥98%
|
|
|
2005-05-18
|
14.209844826410
|
ketoprofen
|
2-(3-benzoylphenyl)propionic Acid; Oruvail; Orudis
|
COX cyclooxygenases NSAIDS nonsteroidal non-steroidal anti-inflammatory drugs prostaglandins PGs inflammations pain racemates racemic R-enantiomers cytokines non-selective inhibits inhibitor inhibition |
14.209844826410
|
| 9001148 |
Ketorolac
New |
|
74103-06-3 |
≥98%
|
|
|
2012-01-12
|
102.551822259998
|
ketorolac
|
Sprix®; RS 37619; Acular LS®; Acular PF®
|
analgesic NSAIDs COX inhibition inhibits inhibitors ocular pain inflammation PGE2 non steroidal anti-inflammatory antiinflammatory drugs heteroaryl acetic acids derivatives cyclooxygenase opthalmalic solutions ocular COX-1 COX-2 COX1 COX2 racemic 66635-83-4 |
102.551822259998
|
| 70690 |
Ketorolac (tromethamine salt)
|
|
74103-07-4 |
>99%
|
|
|
|
18.743208512379
|
ketorolac-tromethamine-salt
|
Toradol
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits |
18.743208512379
|
| 10007692 |
Licofelone
|
|
156897-06-2 |
≥98%
|
|
|
2006-04-03
|
35.333449969306
|
licofelone
|
ML 3000
|
inibits inhibitors inhibition lipoxygenases LOX cyclooxygenases COX osteoarthritic OA synovial explants arachidonic acids AA shunting interleukins 1.beta. IL-1b synthesis prostaglandins PGE2 leukotrienes LTB4 lipoxins LPS cells non-steroidal anti-inflammatory drugs NSAIDS gastric mucosa parietal acid-secretory mechanisms ML3000 |
35.333449969306
|
| 70550 |
Meclofenamate (sodium salt)
|
|
6385-02-0 |
>99%
|
|
|
|
2.441215469612
|
meclofenamate-sodium-salt
|
|
PPAR cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits peroxisome proliferator-activated receptors |
2.441215469612
|
| 10004910 |
Mouse Macrophage Microsomal Immunoblot Control
|
|
- |
|
|
|
2004-11-09
|
30.565807243707
|
mouse-macrophage-microsomal-immunoblot-control
|
Mouse macrophage microsomes protein
|
western blots blotting microsomes immunoblots immunoblotting positive controls COX-2 COX2 PGHS-2 PGHS2 cyclooxygenases prostaglandins synthases cultures SDS-PAGE |
30.565807243707
|
| 70272 |
N-(2-phenylethyl)-Indomethacin amide
|
|
- |
≥98%
|
|
|
|
12.448042620363
|
n-2-phenylethyl-indomethacin-amide
|
N-2PIA
|
aromatic amides inhibitors inhibits COX-2 COX2 PGHS2 PGHS-2 prostaglandin H synthases cyclooxygenases |
12.448042620363
|
| 10007704 |
N-(3-hydroxyphenyl)-Arachidonoyl amide
Exclusive |
|
183718-75-4 |
>98%
|
|
✓ |
2007-02-02
|
13.166132596685
|
n-3-hydroxyphenyl-arachidonoyl-amide
|
3-HPAA
|
neurochemistry neuroscience AM404 anologs N-(4-hydroxyphenyl)-arachidonoylamides AEA ethanolamides cycloxygenase-1 cyclooxygenase-2 COX-1 COX-2 inhibits inhibitors inhibition N-(3-hydroxyphenyl)-Arachidonoylamide 3-HPA cannabinoids cbs synthetic |
13.166132596685
|
| 70274 |
N-(3-pyridyl)-Indomethacin amide
|
|
- |
≥98%
|
|
|
|
15.172194159431
|
n-3-pyridyl-indomethacin-amide
|
N-3PyIA
|
aromatic amides inhibitors inhibits COX-2 COX2 PGHS2 PGHS-2 prostaglandin H synthases cyclooxygenases COX-1 COX1 PGHS1 PGHS 1 |
15.172194159431
|
| 70278 |
N-(4-acetamidophenyl)-Indomethacin amide
|
|
- |
≥98%
|
|
|
|
14.522716390423
|
n-4-acetamidophenyl-indomethacin-amide
|
N-4AIA
|
aromatic amides inhibitors inhibits COX-2 COX2 PGHS2 PGHS-2 prostaglandin H synthases cyclooxygenases |
14.522716390423
|
| 10008284 |
N-acetyl-2-carboxy Benzenesulfonamide
Exclusive |
|
849067-18-1 |
>98%
|
|
✓ |
2006-05-10
|
12.068987108655
|
n-acetyl-2-carboxy-benzenesulfonamide
|
|
analogs aspirin inhibits inhibitors inhibition cyclooxygenaes COX-1 COX-2 COX1 COX2 |
12.068987108655
|
| 70650 |
Niflumic Acid
|
|
4394-00-7 |
>99%
|
|
|
|
45.572438831886
|
niflumic-acid
|
UP83; Nifluril; Donalgin; Actol
|
selective inhibitors COX-2 PGHS-2 prostaglandins H Synthase 2 acids cyclooxygenase |
45.572438831886
|
| 70640 |
Nimesulide
|
|
51803-78-2 |
>99%
|
|
|
|
51.709812154696
|
nimesulide
|
R805
|
selective inhibitors COX-2 PGHS-2 synthases prostaglandins R-805 cyclooxygenases inhibits |
51.709812154696
|
| 10005705 |
NO-Indomethacin
Exclusive |
|
301838-28-8 |
>98%
|
|
✓ |
2004-10-20
|
6.229944751381
|
no-indomethacin
|
NCX 2121
|
inhibition inhibitors NSAIDs non-steroidal anti-inflammatory drugs inhibits nitric oxides cancer chemopreventative donor gastrointestinal NOs PaCa-2 PaCa2 pancreatic analgesic |
6.229944751381
|
| 70300 |
Nordihydroguaiaretic Acid
|
|
500-38-9 |
>95%
|
|
|
|
22.350773480662
|
nordihydroguaiaretic-acid
|
NDGA
|
lipoxygenases inhibitors inhibits NDGA cyclooxygenase |
22.350773480662
|
| 70590 |
NS-398
|
|
123653-11-2 |
>98%
|
|
|
|
105.368845917740
|
ns-398
|
|
cyclooxygenases inhibitors NSAIDs COX-2 nonsteroidal anti-inflammatory drugs cox2 pghs2 pghs-2 prostaglandins synthases synthase-2 inhibits selective ns398 selectivity neurochemistry |
105.368845917740
|
| 70263 |
O-Acetyl Salicylhydroxamic Acid
|
|
- |
>98%
|
|
|
|
20.136926795580
|
o-acetyl-salicylhydroxamic-acid
|
O-ASHA; AcSHA
|
cyclooxygenases inhibitors COX-1 COX-2 cox1 cox2 pghs1 pghs-1 pghs-2 prostaglandin synthases inhibits nonselective irreversible pghs2 |
20.136926795580
|
| 70400 |
Phenylbutazone
|
|
50-33-9 |
>99%
|
|
|
|
4.443583267560
|
phenylbutazone
|
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits PGIS |
4.443583267560
|
| 75751 |
PPA
|
|
- |
>98%
|
|
|
|
0.430939226519
|
ppa
|
|
peroxidase HPLC standard PPHP cylcooxygenase |
0.430939226519
|
| 75750 |
PPHP
|
|
87864-20-8 |
>98%
|
|
|
|
30.707071823204
|
pphp
|
|
peroxidase substrate cyclooxygenase |
30.707071823204
|
| 10006697 |
Prostaglandin D2-biotin
|
|
- |
>95%
|
|
|
2005-08-03
|
37.306066298342
|
prostaglandin-d2-biotin
|
PGD2-biotin
|
PgD2 biotinylated prostaglandins biotins biotinamide affinity probes ligand receptors PGs |
37.306066298342
|
| 10006987 |
Prostaglandin E2-biotin
|
|
- |
>95%
|
|
|
2005-07-26
|
39.316132596684
|
prostaglandin-e2-biotin
|
PGE2-biotin
|
prostaglandins biotinimides eicosanoids COX-1 COX-2 cyclooxygenases reproductive tissues contracts bronchial smooth muscles regulates fertility implantation FP receptors GPCR affinity probes detected detection interaction biotins ligands transmembrane receptors nucleic acids proteins binding partners tool elucidations mechanisms biotins biotinylated |
39.316132596684
|
| 10006988 |
Prostaglandin F2α-biotin
|
|
- |
>96%
|
|
|
2005-07-26
|
13.537900552486
|
prostaglandin-f2-biotin
|
PGF2α-biotin
|
prostaglandins biotinimides eicosanoids COX-1 COX-2 cyclooxygenases reproductive tissues contracts bronchial smooth muscles regulates fertility implantation FP receptors GPCR affinity probes detected detection interaction biotins ligands transmembrane receptors nucleic acids proteins binding partners tool elucidations mechanisms biotins biotinylated |
13.537900552486
|
| 13900 |
Resveratrol-3-O-Sulfate
|
|
553662-69-4 |
≥98%
|
|
|
2011-06-01
|
27.570370955011
|
resveratrol-3-o-sulfate
|
|
polyphenol phytoalexin biochemicals physiological actions estrogenic antiplatelet anti-inflammatory piceid polydatin grape juices glucuronidated metabolites humans |
27.570370955011
|
| 70255 |
(R)-Flurbiprofen
|
|
51543-40-9 |
≥99%
|
|
|
2004-06-11
|
5.745256511444
|
-r-flurbiprofen
|
E-7869; Tarenflurbil; Flurizan
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits inhibition neurochemistry |
5.745256511444
|
| 10004722 |
RSV Microsomal Immunoblot Control
|
|
- |
|
|
|
2004-05-10
|
14.928145224940
|
rsv-microsomal-immunoblot-control
|
Ram Seminal Vesicle Microsomes; Ovine Seminal Vesicles Microsomes
|
western blots blotting immunoblots immunoblotting positive controls wb |
14.928145224940
|
| 70340 |
SC-560
|
|
188817-13-2 |
>98%
|
|
|
|
62.055383670963
|
sc-560
|
|
SC560 cyclooxygenases prostaglandins synthases COX-1 pghs-1 inhibits inhibitors selective |
62.055383670963
|
| 70655 |
SC-58125
|
|
162054-19-5 |
>98%
|
|
|
|
15.691049723756
|
sc-58125
|
|
selective inhibitors inhibits COX-2 cox2 pghs2 pghs-2 prostaglandin synthases synthase-2 sc58125 cyclooxygenases diaryl heterocycles time-dependent |
15.691049723756
|
| 10004207 |
(S)-Flurbiprofen
|
|
51543-39-6 |
≥99%
|
|
|
2004-06-11
|
4.902762430938
|
-s-flurbiprofen
|
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits inhibition (S)Flurbiprofen |
4.902762430938
|
| 70290 |
(S)-Naproxen
|
|
22204-53-1 |
>99%
|
|
|
|
24.718737262123
|
-s-naproxen
|
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits |
24.718737262123
|
| 10004386 |
Sulindac
|
|
38194-50-2 |
>98%
|
|
|
2004-04-20
|
17.175380260555
|
sulindac
|
|
NSAIDS anti-inflammatory inhibitors inhibits cancer COX non-steroidal nonsteroidal drugs cyclooxygenases indomethacin pghs2 cox2 pghs-2 prostaglandin synthases synthase-2 |
17.175380260555
|
| 10006610 |
Thromboxane B1
|
|
64626-32-0 |
>98%
|
|
|
2005-09-13
|
20.370441988950
|
thromboxane-b1
|
|
thromboxanes TXB1 DGLA dihomo-.gamma.-linolenic acids dihomo-g-linolenic metabolites cyclooxygenases COX-1 TXA synthases 20-carbon fatty metabolized prostaglandins COX-2 metabolism human platelets 1-series 12-lipoxygenases 12-LO specific biomarkers ethanol abuses |
20.370441988950
|
| 70450 |
TMB (hydrochloride hydrate)
|
|
207738-08-7 |
>98%
|
|
|
|
216.194116022100
|
tmb-hydrochloride-hydrate
|
|
oxidation heme peroxidases hydroperoxides 2HCl diamines cyclooxygenase dihydrochloride dihydrate 64285-73-0 |
216.194116022100
|
| 70455 |
TMPD (hydrochloride)
|
|
637-01-4 |
>95%
|
|
|
|
108.812513812155
|
tmpd-hydrochloride
|
Wurster's Reagent; N,N,N',N'-Tetramethyl-p-Phenylenediamine
|
oxidation heme peroxidases hydroperoxides polyacrylamides gels cyclooxygenase |
108.812513812155
|
| 70675 |
trans-Resveratrol
|
|
501-36-0 |
>98%
|
|
|
|
96.100285851549
|
trans-resveratrol
|
(E)-Resveratrol
|
selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins 3,5,4'-trihydroxystilbene 3,5,4'-trihydroxy-trans-stilbene 3,5,4'-THS 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene (E)-stilbenes AHR antagonists aryl hydrocarbon receptors |
96.100285851549
|
| 13130 |
trans-Resveratrol-d4
|
|
- |
≥99% deuterated product
|
|
|
2009-01-14
|
18.699378453038
|
trans-resveratrol-d4
|
(E)-Resveratrol-d4
|
selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis deuterated LC/MS GC-MS LC-MS mass spectrometry deuterium sirtuins AHR antagonists aryl hydrocarbon receptors |
18.699378453038
|
| 70670 |
Valeroyl Salicylate
|
|
64206-54-8 |
>99%
|
|
|
|
0.632504604051
|
valeroyl-salicylate
|
2-Valeryloxybenzoic Acid
|
selective cyclooxygenase inhibitors COX-1PGHS-1 prostaglandin H synthase 1 prostaglandins |
0.632504604051
|